Third-line pharmacotherapy for type 2 diabetes erratum

CADTH
Record ID 32014000774
English
Authors' objectives: Correction to an error identified in the CADTH report "Third-line pharmacotherapy for type 2 diabetes —update" published in July 2013
Authors' recommendations: Correction to an error identified in the CADTH report "Third-line pharmacotherapy for type 2 diabetes —update" published in July 2013. The correction of this error did not alter the overall conclusions regarding the comparative efficacy of the third-line drugs studied with respect to A1C.
Details
Project Status: Completed
Year Published: 2014
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Humans
  • Diabetes Mellitus, Type 2
  • Metformin
  • Hypoglycemic Agents
  • Published Erratum
Contact
Organisation Name: Canadian Agency for Drugs and Technologies in Health
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name: requests@cadth.ca
Contact Email: requests@cadth.ca
Copyright: Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.